Lucas Ward
Stock Analyst at Ascendiant Capital
(1.16)
# 3,604
Out of 4,944 analysts
17
Total ratings
47.06%
Success rate
-22.07%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIQT LiqTech International | Maintains: Buy | $3.4 → $3.6 | $1.93 | +86.53% | 5 | Jun 16, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $5.8 → $7 | $1.35 | +418.52% | 2 | Jun 2, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.6 → $6.2 | $4.61 | +34.49% | 3 | Apr 15, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $14 | $3.51 | +298.86% | 2 | Mar 18, 2025 | |
| ACON Aclarion | Maintains: Buy | $555 → $481 | $7.09 | +6,684.11% | 3 | Nov 27, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $3.33 | +80,981.08% | 2 | Jul 29, 2024 |
LiqTech International
Jun 16, 2025
Maintains: Buy
Price Target: $3.4 → $3.6
Current: $1.93
Upside: +86.53%
60 Degrees Pharmaceuticals
Jun 2, 2025
Maintains: Buy
Price Target: $5.8 → $7
Current: $1.35
Upside: +418.52%
Vivos Therapeutics
Apr 15, 2025
Maintains: Buy
Price Target: $6.6 → $6.2
Current: $4.61
Upside: +34.49%
HeartSciences
Mar 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $3.51
Upside: +298.86%
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $555 → $481
Current: $7.09
Upside: +6,684.11%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $3.33
Upside: +80,981.08%